TY  - GEN
AU  - Juanola Roura,Xavier
AU  - Zarco Montejo,Pedro
AU  - Sanz Sanz,Jesús
AU  - Muñoz Fernández,Santiago
AU  - Mulero Mendoza,Juan
AU  - Linares Ferrando,Luis Francisco
AU  - Gratacós Masmitja,Jordi
AU  - García de Vicuña,Rosario
AU  - Fernandez Carballido,Cristina
AU  - Collantes Estevez,Eduardo
AU  - Batlle Gualda,Enrique
AU  - Ariza Ariza,Rafael
AU  - Loza Santamaría,Estíbaliz
TI  - [Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis]
SN  - 1885-1398
PY  - 2012///0202
KW  - Adalimumab
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antirheumatic Agents
KW  - Biological Therapy
KW  - methods
KW  - Drug Therapy, Combination
KW  - Etanercept
KW  - Humans
KW  - Immunoglobulin G
KW  - Infliximab
KW  - Methotrexate
KW  - Receptors, Tumor Necrosis Factor
KW  - Spondylarthritis
KW  - classification
KW  - Sulfasalazine
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.reuma.2010.12.002
ER  -